Understanding The Likely Population Impact Of New And Improved Influenza Vaccines
Funder
National Health and Medical Research Council
Funding Amount
$358,678.00
Summary
Influenza causes a large burden of death and disease each year, as well as disruptive pandemics. Vaccines that could protect against more than one season�s flu strains (including new pandemic viruses) would be highly desirable, and may be on the horizon. Our aim is to understand the likely impact of these new vaccines on the way flu viruses spread between people, and change from one season to the next. This information is needed to justify their introduction, and inform their best use.
Assessing Acellular Pertussis Vaccine Effectiveness: Integrating Transmission Models, Genetics And Cohort Data To Inform Policy
Funder
National Health and Medical Research Council
Funding Amount
$429,597.00
Summary
Between 2009-12 a very large epidemic of whooping cough occurred in Australia. More surprisingly during the course of the epidemic the bacteria that cause whooping cough showed genetic changes that seemed to avoid protection provided by the current vaccine against whooping cough in Australia. This grant seeks to use mathematical models of whooping cough transmission to explain how this occurred and to establish whether alternative vaccination strategies might improve the control of this disease.
Risk Factors For Long-term Chronic Disease Events In HIV-positive Persons: The D:A:D Cohort Study
Funder
National Health and Medical Research Council
Funding Amount
$925,659.00
Summary
The D:A:D Study is a large, international study assessing risk factors for chronic disease events in HIV-positive patients. We know these events, such as heart attacks and cancers, increase with age. And we also know that these events are more common in HIV-positive people. Over the next five years, D:A:D will assess risk factors for chronic disease events in HIV-positive people as they age, and help optimise patient monitoring and management.
Enterovirus, Vitamin D Status And Inflammation At The Clinical Onset Of Type 1 Diabetes In Childhood
Funder
National Health and Medical Research Council
Funding Amount
$410,542.00
Summary
Type 1 diabetes is a serious disease that is increasing in incidence among Australian children. This project will build on an exsisting study to provide new information on the role of enteroviral infection, vitamin D status and the associated inflammatory changes in blood at the onset of disease.
HIV Pre-exposure Prophylaxis In Men Who Have Sex With Men: Investigating Impacts On HIV Incidence And Novel Methods Of Engagement
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
HIV infections are increasing in gay men and other men who have sex with men (MSM) in Australia and Indonesia. A promising new HIV prevention strategy is HIV pre-exposure prophylaxis (PrEP), which involves HIV-negative individuals taking one pill containing HIV treatments per day to prevent infection. PrEP is highly effective when taken correctly. Access to PrEP is currently very limited. Studies to investigate the best ways to implement PrEP services are required in Australia and Indonesia.
HIV Treatment As Prevention: A Longitudinal Assessment Of Population Effectiveness
Funder
National Health and Medical Research Council
Funding Amount
$783,160.00
Summary
This project is a large-scale evaluation of an HIV strategy known as ‘treatment as prevention’ (TasP). Through routine and repeat HIV testing for gay men and early treatment initiation following diagnosis, TasP aims to reduce HIV community infection rates. Through the establishment of a large cohort of gay men in NSW and Victoria, this study will track HIV testing, treatment and management to assess the real-world efficacy of TasP for reducing HIV infections among this at-risk population.
People With HIV Still Die Young – Preventing Non-AIDS-associated Comorbidity
Funder
National Health and Medical Research Council
Funding Amount
$408,768.00
Summary
There are over 36 million people in the world infected with HIV. While people with HIV can now live an almost normal life through the use of medication, they have a very high risk of heart problems, cancer and other common illnesses. It is important to find ways of reducing the cost of treating these common illnesses and to make sure that people with HIV can live a long, happy life. This project aims to find the best ways to stop people with HIV getting heart trouble or dying from liver cancer.
Evaluating The Burden And Aetiology Of Medical Comorbidities Among People With HIV In Australia: Towards The Optimal Management Of The Ageing HIV Positive Population
Funder
National Health and Medical Research Council
Funding Amount
$105,599.00
Summary
People with HIV are living longer due to better HIV medications. People with HIV also have more medical problems (like heart disease and cancer) than HIV negative persons. Therefore, treating these other medical conditions is becoming a larger part of caring for people with HIV. This research focuses on: 1) Understanding how common these medical conditions are among people with HIV; and 2) Identifying the reasons behind why people with HIV have more medical problems than HIV negative people.